The BPD Biopharmaceutical Bioprocess Development Summit is an industry benchmark event focusing on the entire workflow of biopharmaceutical process development to commercial manufacturing. Since the first summit was held in China in 2017, BPD has continuously dedicated itself to frontier technology exchange, product user interaction, and connecting the upstream and downstream of the industry. Through covering segmented biopharmaceutical product tracks, breaking down CMC segments such as R&D, process, quality, and production, and focusing on technical reports and case studies, BPD promotes biopharmaceutical process technology exchange across global regions via a combination of annual conferences and regional summits. BPD US will focus on innovative American biotechs and MNCs to jointly explore new breakthroughs in the CMC field. Meanwhile, BPD Boston will join hands with repr esentative Chinese biotechs, biopharmas, and outstanding Chinese upstream suppliers and service providers to "go global" together, exploring global cooperation opportunities.

Key Highlights

• Focus on the core pain points and innovation directions of Sino US biopharmaceutical CMC, connect global process leaders, and jointly explore efficient, stable, and forward-looking process development and production strategies.

• Participants are Vice Presidents (Process-related) and Process background Chief Executive Officers from Sino-U.S. biopharmaceutical enterprises; Representatives from U.S.-based MNCs and biotech companies; Process leads of leading Chinese biotech and pharmaceutical companies